Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
2(40%)
Results Posted
100%(2 trials)

Phase Distribution

Ph phase_4
1
20%
Ph phase_3
3
60%

Phase Distribution

0

Early Stage

0

Mid Stage

4

Late Stage

Phase Distribution4 total trials
Phase 3Large-scale testing
3(75.0%)
Phase 4Post-market surveillance
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

2

trials recruiting

Total Trials

5

all time

Status Distribution
Active(3)
Completed(2)

Detailed Status

Recruiting2
Completed2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 33 (75.0%)
Phase 41 (25.0%)

Trials by Status

recruiting240%
completed240%
not_yet_recruiting120%

Recent Activity

2 active trials
Showing 5 of 5
recruitingphase_3

Dabigatran Versus Apixaban in Cerebral Venous Thrombosis

NCT06551415
recruitingphase_3

Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis

NCT06551402
not_yet_recruiting

Population Pharmacokinetic Study of the Effect of Polymorphisms in the ABCB1 and CES1 Genes on the Pharmacokinetics of Dabigatran

NCT06387407
completedphase_3

Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

NCT02164864
completedphase_4

Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

NCT02348723

Clinical Trials (5)

Showing 5 of 5 trials
NCT06551415Phase 3

Dabigatran Versus Apixaban in Cerebral Venous Thrombosis

Recruiting
NCT06551402Phase 3

Dabigatran Versus Rivaroxaban in Cerebral Venous Thrombosis

Recruiting
NCT06387407

Population Pharmacokinetic Study of the Effect of Polymorphisms in the ABCB1 and CES1 Genes on the Pharmacokinetics of Dabigatran

Not Yet Recruiting
NCT02164864Phase 3

Evaluation of Dual Therapy With Dabigatran vs. Triple Therapy With Warfarin in Patients With AF That Undergo a PCI With Stenting (REDUAL-PCI)

Completed
NCT02348723Phase 4

Uninterrupted Dabigatran Etexilate in Comparison to Uninterrupted Warfarin in Pulmonary Vein Ablation (RE-CIRCUIT)

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5